Nexgenia
Seattle
About Nexgenia
Nexgenia develops and manufactures proprietary stimuli-responsive polymers and polymer-containing magnetic nanoparticles. These polymers change state from soluble single macromolecules to large insoluble aggregates in response to very modest changes (like temperature, pH, and salt) in their environment. When these polymers are attached to other chemicals/biologicals, they confer the same environmentally-responsive characteristics. Thus the resulting combinations can be small when it is advantageous to be small and large when that facilitates separation and analysis. This property enables the development of faster, more complete molecular/cellular separations and faster, more sensitive immunoassays. Nexgenia was founded in 2011 and is headquartered in Seattle, Washington.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $3.5M
- Last round: Series Unknown (Aug 2016)
- Website: nexgeniacorp.com
- Phone: (206) 221-1855
Industries & Categories
Biotechnology, Life Science, Manufacturing, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/nexgenia-113769 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.